Search alternatives:
longer decrease » largest decrease (Expand Search)
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
longer decrease » largest decrease (Expand Search)
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
-
201
-
202
-
203
-
204
-
205
-
206
-
207
Phosphorylation as an Effective Tool to Improve Stability and Reduce Toxicity of Antimicrobial Peptides
Published 2024“…Among them, W<sub>3</sub>BipY<sub>8</sub>-P stood out as the most promising peptide, exhibiting similar antibacterial activity as its unphosphorylated analog W<sub>3</sub>BipY<sub>8</sub> but with significantly reduced hemolytic activity (19-fold decrease), cytotoxicity (3.3-fold decrease), and an extended serum half-life 6.3 times longer than W<sub>3</sub>BipY<sub>8</sub>. …”
-
208
-
209
Assignment of interventions to community health centers (CHCs) in districts.
Published 2024Subjects: -
210
Estimated effects of the intervention packages on the incidence of NCDs metabolic risk factors.
Published 2024Subjects: -
211
The difference in NCDs metabolic risk factors’ prevalence between the two surveys.
Published 2024Subjects: -
212
-
213
Demographic and economic characteristics of participants (frequencies and percentages).
Published 2024Subjects: -
214
-
215
-
216
-
217
-
218
-
219
Restricted cubic spline plots showing the association between changes in PAL and risk of CVD.
Published 2025Subjects: -
220
Flowchart of the screening process.
Published 2025“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”